Why Is BTAI stock dropping：Why BioXcel Therapeutics Stock Is Getting Crushed Today
Why BioXcel Therapeutics Stock Is Getting Crushed Today
2023年8月14日—Theclinical-stagebiotechspecialist'ssharepriceisdown44.6%asof11:15a.m.ET,accordingtodatafromS&PGlobalMarketIntelligence.。其他文章還包含有：「FurtherweaknessasBioXcelTherapeutics(NASDAQ」、「BTAIstockplungesto52」、「BioXcelTherapeutics」、「BioXcelTherapeutics(BTAI)MayFindaBottomSoon...」、「WhyIsBioXcelTherapeutics(BTAI)StockDown26%Today?」、「BTAIstockplungesto52」、「BioXcelT...
查看更多 離開網站
Further weakness as BioXcel Therapeutics (NASDAQ
https://finance.yahoo.com
BioXcel Therapeutics had cash in excess of all liabilities of just US$38m when it last reported (June 2023). So if it hasn't remedied the situation already, it will almost certainly have to raise more capital soon. With that in mind, you can understan
BTAI stock plunges to 52
https://www.investing.com
Investors have been reacting to a combination of factors, including market volatility and concerns specific to BioXcel's operations and drug ...
BioXcel Therapeutics
https://finance.yahoo.com
BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.50.
BioXcel Therapeutics (BTAI) May Find a Bottom Soon ...
https://www.nasdaq.com
When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of ...
Why Is BioXcel Therapeutics (BTAI) Stock Down 26% Today?
https://investorplace.com
BioXcel Therapeutics stock is falling on Friday after the company announced plans for a proposed public offering of BTAI shares.
BTAI stock plunges to 52
https://in.investing.com
BTAI stock plunges to 52-week low of $1.03 amid market challenges. ... market for 5 years over fraudulent scheme, shares of ADAG cos fall.
BioXcel Therapeutics Reports Third Quarter 2024 Financial ...
https://www.stocktitan.net
The company's cost reduction initiatives through workforce reductions have significantly lowered operating expenses, with R&D dropping 74% to ...
BTAI Stock Crashes After Agitation Pill Misses Its Mark
https://www.investors.com
BTAI stock plummeted Thursday after BioXcel's Igalmi missed the mark in patients with agitation due to schizophrenia or bipolar disorders.
Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today?
https://investorplace.com
BioXcel Therapeutics (BTAI) stock is falling on job cuts. This has it reducing its headcount from 190 workers to about 80. That comes as it ...